![](https://i.dailymail.co.uk/1s/2024/06/27/19/86663121-0-image-a-7_1719514668442.jpg)
Nearly £5bn wiped off value of GSK as US restricts blockbuster respiratory vaccine
By Leah Montebello Updated: 17:02 EDT, 27 June 2024 Nearly £5billion was wiped off the value of GSK after a top US health agency limited the scope of its blockbuster respiratory vaccine. In a further setback for the UK pharmaceutical giant, the US public …